Cargando…
Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease
BACKGROUND & AIMS: The new name and diagnostic criteria of metabolic-associated fatty liver disease (MAFLD) was proposed in 2020. Although chronic HBV infection has protective effects on lipid profiles and hepatic steatosis, the impact of chronic HBV infection on clinical outcomes of MAFLD requi...
Autores principales: | Cheng, Yu-Ming, Hsieh, Tsung-Han, Wang, Chia-Chi, Kao, Jia-Horng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432217/ https://www.ncbi.nlm.nih.gov/pubmed/37600956 http://dx.doi.org/10.1016/j.jhepr.2023.100836 |
Ejemplares similares
-
Erratum to ‘Impact of HBV infection on clinical outcomes in patients with metabolic dysfunction-associated fatty liver disease’ (JHEP Reports 5 [2023] 100836)
por: Cheng, Yu-Ming, et al.
Publicado: (2023) -
Risk stratification of HBV infection in Asia-Pacific region
por: Kao, Jia-Horng
Publicado: (2014) -
Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease
por: Huang, Shang-Chin, et al.
Publicado: (2021) -
Metabolic dysfunction-associated fatty liver disease is an early predictor for testosterone deficiency in aging men without metabolic syndrome
por: Liu, Chia-Chu, et al.
Publicado: (2023) -
Community-centered Disease Severity Assessment of Metabolic Dysfunction-associated Fatty Liver Disease
por: Huang, Jee-Fu, et al.
Publicado: (2023)